Compare Strategy Inc. (MSTR) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Strategy Inc. vs Summit Therapeutics Inc — how do they compare? Strategy Inc. trades at $97.5 (market cap $37.84B), while Summit Therapeutics Inc trades at $15.4 (market cap $12.06B). The key difference: Strategy Inc. is far larger — about 3.1× Summit Therapeutics Inc's market cap, and Summit Therapeutics Inc is trading nearer its 52-week high, Strategy Inc. nearer its low. Which is the better fit depends on your goals.
| MSTR | SMMT | |
|---|---|---|
Market Cap | $37.84B | $12.06B |
Sector | Technology | Health |
52-Week High | $394.39 | $26.98 |
52-Week Low | $82.31 | $12.55 |
Enterprise Value | $56.61B | $11.39B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Strategy Inc.
MicroStrategy Inc is a provider of enterprise analytics and mobility software. It offers MicroStrategy Analytics platform that delivers reports and dashboards and enables users to conduct ad hoc analysis and share insights through mobile devices or the Web
Read more on MSTR →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
